retatrutide phase 2 Delivers Significant Hemoglobin A1C Reduction, Weight Loss in 3 Type Diabetes Trial VisualAbstract: Retatrutide reduces body weight

Abubakar M, Nama L, Ansari MA, Ansari MM, Bhardwaj S, Daksh R, Syamala KLV, Jamadade MS, Chhabra V, Kumar D, Kumar N (2024) GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for Combating Alzheimers Disease through its Supporting DPP4 Inhibitors: A Review

However, whether these effects are mediated through GLP-1 or GIP pathways remains unclear

Despite the tension, in April 2025, Novo Nordisk and Hims & Hers announced a long-term collaboration to make obesity care and treatments more accessible and affordable

Shaking can cause the delicate peptide chains to break apart or denature, which may render the compound ineffective

Exenatide once weekly contains the same active drug as exenatide twice daily, but it is encapsulated in dissolvable microspheres (13)